DHR vs GOOG: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Alphabet Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Danaher Corporation · Healthcare
$174.04
+13.2% upside to fair value
Grade B
VS
Alphabet Inc. · Communication Services
$339.40
-4.4% upside to fair value
Grade D
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+13.2%).
GOOG trades at a lower forward P/E
(31.2x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
GOOG |
| Current Price |
$174.04 |
$339.40 |
| Fair Value Estimate |
$197.01 |
$324.34 |
| Upside to Fair Value |
+13.2%
|
-4.4%
|
| Market Cap |
$123.2B |
$4,105.7B |
| Forward P/E |
33.4x
|
31.2x
|
| EV / EBITDA |
20.3x
|
23.1x
|
| Price / Sales |
5.0x
|
10.3x
|
| Price / FCF |
23.3x
|
56.4x
|
| Revenue Growth YoY |
+3.7%
|
+11.3%
|
| Gross Margin |
60.7%
|
59.7%
|
| Operating Margin |
21.0%
|
32.0%
|
| Return on Equity |
7.1%
|
35.0%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.3%
|
1.77%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Danaher Corporation is a diversified healthcare company focused on medical diagnostics, life sciences, and biotechnology, generating approximately $24 billion in revenue with a strong recurring revenue base of over 81%. The company benefits from a high gross margin of 60.7% and solid operating margin of 21%, supported by a seasoned management team with a proven capital allocation track record inc…
Alphabet Inc. operates as a global leader in internet content, advertising, cloud computing, and AI technologies, with dominant market positions in search, browser, and mobile operating systems. The company benefits from a high-quality business model characterized by a durable competitive moat, strong revenue growth of 11.3% year-over-year, and robust profitability with net margins of 32.8%. Desp…
Accumulation Zones
| Metric |
DHR |
GOOG |
| Zone Low |
$147.76 |
$243.25 |
| Zone High |
$167.46 |
$275.69 |
| In Buy Zone? |
No
|
No
|